Arch Venture Management, LLC Fate Therapeutics Inc Transaction History

Arch Venture Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 05, 2020	SELL	$13.39 - $20.73 $9.59 Million - $14.9 Million	-716,392 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$15.47 - $22.5 $3.97 Million - $5.78 Million	-256,798 Reduced 26.39%	716,392 $11.1 Million
Q2 2019 Aug 09, 2019	SELL	$15.61 - $20.44 $4.68 Million - $6.13 Million	-300,000 Reduced 23.56%	973,190 $19.8 Million
Q1 2019 May 14, 2019	SELL	$13.15 - $18.71 $10.5 Million - $15 Million	-800,000 Reduced 38.59%	1,273,190 $0
Q4 2018 Feb 14, 2019	BUY	$11.48 - $16.98 $23.8 Million - $35.2 Million	2,073,190 New	2,073,190 $26.6 Million

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $235M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Arch Venture Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Arch Venture Management, LLC with notifications on news.